These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 20167527)

  • 1. Fluorescent blue lights, injecting drug use and related health risk in public conveniences: findings from a qualitative study of micro-injecting environments.
    Parkin S; Coomber R
    Health Place; 2010 Jul; 16(4):629-37. PubMed ID: 20167527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk, shame and the public injector: a qualitative study of drug injecting in South Wales.
    Rhodes T; Watts L; Davies S; Martin A; Smith J; Clark D; Craine N; Lyons M
    Soc Sci Med; 2007 Aug; 65(3):572-85. PubMed ID: 17475383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public injection settings in Vancouver: physical environment, social context and risk.
    Small W; Rhodes T; Wood E; Kerr T
    Int J Drug Policy; 2007 Jan; 18(1):27-36. PubMed ID: 17689341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public injecting drug use and the social production of harmful practice in high-rise tower blocks (London, UK): a Lefebvrian analysis.
    Parkin S; Coomber R
    Health Place; 2011 May; 17(3):717-26. PubMed ID: 21440483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A qualitative study of the perceived effects of blue lights in washrooms on people who use injection drugs.
    Crabtree A; Mercer G; Horan R; Grant S; Tan T; Buxton JA
    Harm Reduct J; 2013 Oct; 10():22. PubMed ID: 24099145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Injection drug users' perceptions regarding use of a medically supervised safer injecting facility.
    Petrar S; Kerr T; Tyndall MW; Zhang R; Montaner JS; Wood E
    Addict Behav; 2007 May; 32(5):1088-93. PubMed ID: 16930849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver's safer injection facility.
    Kerr T; Small W; Moore D; Wood E
    Int J Drug Policy; 2007 Jan; 18(1):37-45. PubMed ID: 17689342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using the health belief model to predict injecting drug users' intentions to employ harm reduction strategies.
    Bonar EE; Rosenberg H
    Addict Behav; 2011 Nov; 36(11):1038-44. PubMed ID: 21763076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risky injecting practices associated with snowballing: a qualitative study.
    Wilkins L; Bissell P; Meier PS
    Drug Alcohol Rev; 2010 May; 29(3):256-62. PubMed ID: 20565517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is groin injecting an ethical boundary for harm reduction?
    Miller PG; Lintzeris N; Forzisi L
    Int J Drug Policy; 2008 Dec; 19(6):486-91. PubMed ID: 18024001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injecting drug users: a stigmatised and stigmatising population.
    Simmonds L; Coomber R
    Int J Drug Policy; 2009 Mar; 20(2):121-30. PubMed ID: 17981451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring motivations to stop injecting in English prisons: qualitative research with former male prisoners.
    Tompkins CN
    Int J Prison Health; 2013; 9(2):68-81. PubMed ID: 25758439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Public injecting among a cohort of injecting drug users in Vancouver, Canada.
    DeBeck K; Small W; Wood E; Li K; Montaner J; Kerr T
    J Epidemiol Community Health; 2009 Jan; 63(1):81-6. PubMed ID: 18628270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syringe exchanges: a public health response to problem drug use.
    Cox GM; Lawless MC; Cassin SP; Geoghegan TW
    Ir Med J; 2000; 93(5):143-6. PubMed ID: 11072923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing prevalence of HIV, and persistent high-risk behaviours among drug users in Bangladesh: need for a comprehensive harm reduction programme.
    Islam MM; Conigrave KM
    Drug Alcohol Rev; 2007 Jul; 26(4):445-54. PubMed ID: 17564883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injecting drug users' experiences of targeted harm reduction in the Russian Federation.
    Power R; Nozhkina N; Kanarsky I
    Drug Alcohol Rev; 2005 Jan; 24(1):69-77. PubMed ID: 16191724
    [No Abstract]   [Full Text] [Related]  

  • 17. Opioid dependent patients' experiences of and attitudes towards having their injecting sites examined.
    Winstock AR; Nittis M; Whitton G; Lea T
    Int J Drug Policy; 2009 Jan; 20(1):85-9. PubMed ID: 18164193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'You sort of switch off': exploring mindlessness in injecting drug users' accounts of blood.
    Treloar C
    J Health Psychol; 2005 Jan; 10(1):137-45. PubMed ID: 15576505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex and drugs: the correlations of injecting drug users' risk perception and behavioral patterns.
    Márványkövi F; Melles K; Rácz J
    Subst Use Misuse; 2009; 44(4):569-77. PubMed ID: 19266355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the injecting risk behaviour of injecting drug users in London, 1990-1993.
    Hunter GM; Donoghoe MC; Stimson GV; Rhodes T; Chalmers CP
    AIDS; 1995 May; 9(5):493-501. PubMed ID: 7639975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.